The son of an Alabama woman who passed away in 2005 from a brain hemorrhage was recently awarded a $5 million judgment after a jury declared that the doctor that had been treating his mother was guilty of negligence. Dr. Frank Gillis had been treating Florine Bryant for atrial fibrillation, which is the most common form of an irregular heartbeat.
Dr. Gillis had previously been cleared of any wrongdoing in 2010, but an appeal reversed the initial decision and allowed for Bryant’s son, Joey Frazier, to pursue damages for medical malpractice.
Left untreated, atrial fibrillation can cause stroke and even death, but with proper monitoring and treatment, the patient can live a long, normal life. Bryant’s death, however, was argued as a scenario in which the patient was the victim of medical malpractice, as Dr. Gillis didn’t properly test Bryant for side effects and complications from the prescription medication Coumadin.
Coumadin is a drug that is generally prescribed to counter thrombosis (blood clots) and embolisms (blood clots that lodge in veins or arteries); however, without sufficient blood testing of a patient, excessive bleeding can develop and significantly complicate the patient’s health. In Bryant’s case, a lack of testing and supervision led to her death.
Frazier was awarded $5 million by the Colbert County Circuit Court because his attorneys proved that Gillis’ negligence ultimately led to his mother’s fatal complications from using the prescription medication.
Source:
Sherer, Dennis. The Times Daily. “Colbert jury awards $5 million in medical malpractice lawsuit”. 06/16/2012.
Frequently Asked Questions
Tumors of the uterine cervix are known as cervical polyps, sometimes these polyps can be growths as opposed to cancerous tumors. The cervix is an important organ as it is what connects the uterus to the vagina. Polyps in the cervix are most often benign; however, there are instances in which these growths are a
Read More
Locked-in syndrome is not immediately fatal on its own. But it generally leads to medical complications that shorten the lives of affected persons. According to a study published in the Orphanet Journal of Rare Diseases (OJRD), even a locked-in syndrome patient who is medically stable has only a 40% chance of living another 20 years,
Read More